Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (231-240 of 374) with videos related to

Pageof 38
Sort By:
Blood|October 30, 2014
Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHDAnne-Kathrin Hechinger, Benjamin A H Smith, Ryan Flynn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2025
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 StudyRobert Zeiser, Domenico Russo, Ron Ram, et al.
Leukemia Research|August 1, 2018
Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantationSebastian Sommer, Marjan Cruijsen, Rainer Claus, et al.
Haematologica|August 19, 2021
Therapeutic targeting of endoplasmic reticulum stress in acute graft-<i>versus</i>-host diseaseEileen Haring, Geoffroy Andrieux, Franziska M Uhl, et al.
Journal of Cancer|November 24, 2016
Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall SurvivalJasmin H Shahinian, Hannah Fuellgraf, Stefan Tholen, et al.
Leukemia|June 25, 2024
How risky is a second allogeneic stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2019
Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease LethalityGovindarajan Thangavelu, Yu-Chi Lee, Michael Loschi, et al.
Blood|April 9, 2014
Activity of therapeutic JAK 1/2 blockade in graft-versus-host diseaseSilvia Spoerl, Nimitha R Mathew, Michael Bscheider, et al.
The EMBO Journal|December 15, 2015
Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutantsMartin Köhler, Michael Röring, Björn Schorch, et al.
International Journal of Hematology|May 25, 2024
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trialTakanori Teshima, Yasushi Onishi, Koji Kato, et al.
Pageof 38

Showing results (231-240 of 374) with videos related to

Sort By:
Pageof 38
Blood|October 30, 2014
Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHDAnne-Kathrin Hechinger, Benjamin A H Smith, Ryan Flynn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2025
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 StudyRobert Zeiser, Domenico Russo, Ron Ram, et al.
Leukemia Research|August 1, 2018
Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantationSebastian Sommer, Marjan Cruijsen, Rainer Claus, et al.
Haematologica|August 19, 2021
Therapeutic targeting of endoplasmic reticulum stress in acute graft-<i>versus</i>-host diseaseEileen Haring, Geoffroy Andrieux, Franziska M Uhl, et al.
Journal of Cancer|November 24, 2016
Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall SurvivalJasmin H Shahinian, Hannah Fuellgraf, Stefan Tholen, et al.
Leukemia|June 25, 2024
How risky is a second allogeneic stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2019
Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease LethalityGovindarajan Thangavelu, Yu-Chi Lee, Michael Loschi, et al.
Blood|April 9, 2014
Activity of therapeutic JAK 1/2 blockade in graft-versus-host diseaseSilvia Spoerl, Nimitha R Mathew, Michael Bscheider, et al.
The EMBO Journal|December 15, 2015
Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutantsMartin Köhler, Michael Röring, Björn Schorch, et al.
International Journal of Hematology|May 25, 2024
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trialTakanori Teshima, Yasushi Onishi, Koji Kato, et al.
Pageof 38